Annals ofAutoimmunity

Volume: 3 - Number: 23 - May 15, 2004

Outstanding

Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus

Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease

Peptide-based treatment for autoimmune diseases: learning how to handle a double-edged sword

Novel approaches to gene expression analysis of active polyarticular juvenile rheumatoid arthritis

Active polyarticular juvenile in rheumatoid arthritis

Novel approaches to gene expression analysis of active polyarticular juvenile rheumatoid arthritis

Anti-Golgi complex

Giantin is the major Golgi autoantigen in human anti-Golgi complex sera

Antitumor immunity

Intratumoral IL-12 and TNF-–Loaded Microspheres Lead To Regression of Breast Cancer and Systemic Antitumor Immunity

Aricular cartilage and metalloproteinase

Does protein kinase R mediate TNF-?- and ceramide-induced increases in expression and activation of matrix metalloproteinases in articular cartilage by a novel mechanism?

Autoimmune diabetes

Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide

Tracking autoimmune T cells in diabetes

Autoimmune diabetes and multiple sclerosis

Type I Diabetes and Multiple Sclerosis Patients Target Islet Plus Central Nervous System Autoantigens; Nonimmunized Nonobese Diabetic Mice Can Develop Autoimmune Encephalitis

Autoimmune experimental pharmacology

Low-Dose Estrogen Therapy Ameliorates Experimental Autoimmune Encephalomyelitis in Two Different Inbred Mouse Strains

Autoimmune model diseases

Regulatory functions of CD8+CD28– T cells in an autoimmune disease model

Autoimmune pharmacology

Intramuscular electroporation with the pro-opiomelanocortin gene in rat adjuvant arthritis

Peptide-based treatment for autoimmune diseases: learning how to handle a double-edged sword

Autoimmune T cell reactivity

Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity

Autoimmunity

Folic Acid and the Prevention of Neural-Tube Defects

Experimental Arthritis

Susceptibility to collagen-induced arthritis is modulated by TGF? responsiveness of T cells

Experimental autoimmune encephalomyelitis

Costimulation-Dependent Modulation of Experimental Autoimmune Encephalomyelitis by Ligand Stimulation of V14 NK T Cells

Cutting Edge: C3, a Key Component of Complement Activation, Is Not Required for the Development of Myelin Oligodendrocyte Glycoprotein Peptide-Induced Experimental Autoimmune Encephalomyelitis in Mice

IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis

Targeting Dipeptidyl Peptidase IV (CD26) Suppresses Autoimmune Encephalomyelitis and Up-Regulates TGF-1 Secretion In Vivo

Experimental autoimmune encephalomyelitis

Roles of TNF-Related Apoptosis-Inducing Ligand in Experimental Autoimmune Encephalomyelitis

Selective Blocking of Voltage-Gated K+ Channels Improves Experimental Autoimmune Encephalomyelitis and Inhibits T Cell Activation

Experimental pathogenesis of autoimmune encephalomyelitis

Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses

Juvenile polyarticular arthritis: autoimmune pharmacology

Intravenous immunoglobulin treatment of four patients with juvenile polyarticular arthritis associated with persistent parvovirus B19 infection and antiphospholipid antibodies

Organs specifc autoimmunity

Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease

Organs specific autoimunity

Hepatitis C and B Cells: Induction of Autoimmunity and Lymphoproliferation May Reflect Chronic Stimulation Through Cell-Surface Receptors

Rheumatoid Arthritis

Decreased response to IL-12 and IL-18 of peripheral blood cells in rheumatoid arthritis

Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement

Treatment of Rheumatoid Arthritis by Selective Inhibition of T-Cell Activation with Fusion Protein CTLA4Ig

Tumor Necrosis Factor-? Promotes the Expression of Osteoprotegerin in Rheumatoid Synovial Fibroblasts

Systemic Lupus Erythematosus

Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus

Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus

Therapeutic in lupus?

Therapeutic CD154 antibody for lupus: promise for the future?